Novacyt UK Holdings Limited entered into a scheme of arrangement to acquire Yourgene Health Plc (AIM:YGEN) from BGF Investments LP, managed by BGF Investment Management Ltd. and others for £16.6 million on July 3, 2023. The offer price per share is £5.22 for 3,176,959,792 issued shares. The Acquisition will be financed from the existing cash resources of the Novacyt Group. The transaction is subject to the satisfaction or waiver (as applicable) of the Conditions, including, court, Yourgene health shareholders approval. Stifel Nicolaus Europe Limited consider the terms of the Acquisition to be fair and reasonable. Yourgene Health board recommends unanimously that Scheme Shareholders vote, or procure the vote, in favor of the Scheme at the Court Meeting. The Acquisition is currently expected to complete during Q3 2023. As of August 17, 2023, Yourgene Health Plc shareholders approved the scheme in meetings, complying with Court orders. As of September 7, 2023, the Court issued the Court Order sanctioning the Scheme and conditional only upon the delivery of a copy of the Court Order to the Registrar of Companies, which is expected to occur on September 8, 2023. It is expected that, subject to the Scheme becoming Effective on September 8, 2023, the cancellation of the admission to trading of the Yourgene shares on AIM will take effect at or around September 11, 2023. As of September 11, 2023. Yourgene announces that, following an application to the London Stock Exchange, the admission to trading on AIM of Yourgene Shares has been cancelled.

Nicholas Moore, Matthew Blawat, Samira Essebiyea, William Palmer-Brown, Matthew Blawat and Ben Good of Stifel Nicolaus Europe Limited and Liam Murray and Ludovico Lazzaretti of Cairn Financial Advisers LLP acted as financial advisors and Addleshaw Goddard LLP acted as a legal advisor to Yourgene Health. Numis Securities Limited, SP Angel Corporate Finance LLP acted as financial advisors. Tom Page, Alexandra Pygall, Dan Holland, Marta Garcia, Nicolas Stretch and Dan Margolis of Stephenson Harwood LLP acted as legal advisor to Novacyt. Link Group acted as registrar of Yourgene. Alasdair Steele, David Jahoda and Shadi Ameli-Savehchi of CMS Cameron McKenna Nabarro Olswang LLPacted as a legal advisor to Numis Securities Limited.

Novacyt UK Holdings Limited completed the acquisition of Yourgene Health Plc (AIM:YGEN) from BGF Investments LP, managed by BGF Investment Management Ltd. and others on September 8, 2023.